Document is current

Any future updates will be listed below

Selective serotonin reuptake inhibitors use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants

Crossref DOI link: https://doi.org/10.1007/s00228-022-03309-y

Published Online: 2022-03-11

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark